NCT00875537

Brief Summary

Burning mouth syndrome (BMS) is characterized by a bilateral burning sensation in the anterior tongue, hard palate and lips in the absence of any clinical or laboratory findings. The term syndrome implicates the simultaneous presence of oral dryness (xerostomia) and altered taste (dysgeusia) in addition to the burning sensation in the oral mucosa. BMS is most often seen in women and is more frequent during menopause. The etiology and pathogenesis are still unclear but recent studies suggest that BMS is a neuropathic pain condition. The objectives of the study are:

  • To clarify potential neurogenic mechanisms behind BMS using immunohistochemistry (IH) to characterize the localization and distribution of peripheral nerve fibres, neuropeptides like substance P, calcitonin gene-related peptide, nerve growth factor, nerve growth factor receptor, PGP 9.5 neuronal marker and TRPV1 as well as inflammatory/structural changes.
  • To perform a randomized double blind cross-over intervention study to examine the efficacy and safety of topical application of capsaicin oral gel (on the tongue) to relieve the burning sensation in patients with BMS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 2, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 3, 2009

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
Last Updated

March 14, 2017

Status Verified

March 1, 2017

Enrollment Period

1.2 years

First QC Date

April 2, 2009

Last Update Submit

March 11, 2017

Conditions

Keywords

Burning mouth syndromeneuropathyinflammationtongue mucosatongue innervationdysgeusia

Outcome Measures

Primary Outcomes (1)

  • Primary outcome: To evaluate the efficacy and safety of topical application of capsaicin oral gel (using to different concentrations) to relieve the burning sensation in patients with BMS and alleviate BMS related symptoms.

    6 months

Secondary Outcomes (1)

  • To characterize the localization and distribution of peripheral nerve fibres, neuropeptides like substance P, calcitonin gene-related peptide, NGF, NGF-R, PGP 9.5 neuronal marker and TRPV1 as well as inflammatory/structural changes.

    6 months

Study Arms (2)

Capsaicin oral gel 0.01%

ACTIVE COMPARATOR
Other: Capsaicin oral gel 0.01%

Capsaicin oral gel 0.025%

ACTIVE COMPARATOR
Other: Capsaicin oral gel 0.025%

Interventions

Application 3 times daily for 14 days on the tongue, followed by 14 days wash-out

Also known as: Capsicum, extract from chilipepper
Capsaicin oral gel 0.025%

Application 3 times daily for 14 days on the tongue, followed by 14 days wash-out

Also known as: Capsicum, extract from chilipepper
Capsaicin oral gel 0.01%

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • non-smoking female patients with burning mouth syndrome (n=26)
  • healthy aged-matched control group (n=10)

You may not qualify if:

  • women who do not use safe anticonception
  • patients with know allergy/hypersensitivity to capsicum and other capsaicinoid-containing products
  • Active infection which requires antibiotic treatment
  • patients who are able to give informed consent due to physical or mental disabilities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Odontology, Section of Oral Medicine, Clinical Oral Physiology, Oral Pathology & Anatomy

Copenhagen, 2200, Denmark

Location

MeSH Terms

Conditions

Burning Mouth SyndromeInflammationDysgeusia

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsTaste DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, PhD, DDS

Study Record Dates

First Submitted

April 2, 2009

First Posted

April 3, 2009

Study Start

January 1, 2009

Primary Completion

April 1, 2010

Study Completion

June 1, 2010

Last Updated

March 14, 2017

Record last verified: 2017-03

Locations